Alzheimer’s disease medication shows promise for improving social impairment in some youth with autism

Some people with autism spectrum disorder (ASD) have abnormal levels of glutamate in the brain. New research led by Mass General Brigham has focused on this neuron-activating chemical, suggesting that a glutamate-modulating drug called memantine may improve social functioning in youth with ASD who do not have intellectual disabilities.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup